Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Geron Corp (NASDAQ: GERN) closed the day trading at $2.98 down -5.99% from the previous closing price of $3.17. In other words, the price has decreased by -$5.99 from its previous closing price. On the day, 22.48 million shares were traded. GERN stock price reached its highest trading level at $3.102 during the session, while it also had its lowest trading level at $2.8.
Ratios:
For a better understanding of GERN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on November 05, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
On September 09, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $7.Leerink Partners initiated its Outperform rating on September 09, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 08 ’24 when GRETHLEIN ANDREW J sold 674,348 shares for $4.56 per share. The transaction valued at 3,073,004 led to the insider holds 0 shares of the business.
Feller Faye sold 287,900 shares of GERN for $1,334,129 on Jun 10 ’24. The EVP, Chief Medical Officer now owns 0 shares after completing the transaction at $4.63 per share. On Jun 10 ’24, another insider, Kapur Anil, who serves as the EVP, Corp Strategy & CCO of the company, sold 421,875 shares for $4.64 each. As a result, the insider received 1,959,609 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 1916268160 and an Enterprise Value of 1548902016. For the stock, the TTM Price-to-Sale (P/S) ratio is 61.11 while its Price-to-Book (P/B) ratio in mrq is 6.15. Its current Enterprise Value per Revenue stands at 52.541 whereas that against EBITDA is -7.466.
Stock Price History:
The Beta on a monthly basis for GERN is 0.56, which has changed by 0.60913706 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $5.34, while it has fallen to a 52-week low of $1.64. The 50-Day Moving Average of the stock is -22.08%, while the 200-Day Moving Average is calculated to be -27.53%.
Shares Statistics:
Over the past 3-months, GERN traded about 10.17M shares per day on average, while over the past 10 days, GERN traded about 17194740 shares per day. A total of 603.10M shares are outstanding, with a floating share count of 564.66M. Insiders hold about 6.59% of the company’s shares, while institutions hold 78.45% stake in the company. Shares short for GERN as of 1734048000 were 64524457 with a Short Ratio of 6.40, compared to 1731628800 on 70125256. Therefore, it implies a Short% of Shares Outstanding of 64524457 and a Short% of Float of 10.73.
